In this episode of Industry Focus: Wildcard, Motley Fool Analyst Maria Gallagher joins host Emily Flippen to discuss the prospects for 10x Genomics (NASDAQ:TXG), a healthcare tech company looking to reform the way researchers discover single-cell gene expression. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video. This video was recorded on April 21, 2021. Emily Flippen: Welcome to Industry Focus. Today is Wednesday, April 21st, and I am your host, Emily Flippen. Today, I am joined by Motley Fool Analyst Maria Gallagher, as we wade back into the healthcare waters and talk about an interesting play on healthcare tech and consumables, 10x Genomics. Maria, thanks for joining.